The first Russian strategic study of pharmacotherapy for rheumatoid arthritis (REMARCA)

The first Russian strategic study of pharmacotherapy for rheumatoid arthritis (REMARCA)

The international recommendations «Treat to target» (T2T) underline the greatest importance of treatment strategy for the success of treating rheumatoid arthritis (RA). Evaluation of the efficiency of this approach obviously requires special strategic studies with an adaptive design, which substanti...

Full description

Bibliographic Details
Main Authors:	Dmitri Evgenyevich Karateev, E L Luchikhina, Yu V Muravyev, N V Demidova, G I Grineva, D S Novikova, E N Aleksandrova, A A Novikov, A V Smirnov, A V Volkov, A S Avdeyeva, E V Lopareva, Yu A Olyunin, G V Lukina, T V Popkova, E L Nasonov
Format:	Article
Language:	Russian
Published:	IMA-PRESS LLC 2013-04-01
Series:	Научно-практическая ревматология
Subjects:	rheumatoid arthritis treat to target remarca study methotrexate genetically engineered agents
Online Access:	https://rsp.mediar-press.net/rsp/article/view/775

Similar Items

USE OF SUBCUTANEOUS METHOTREXATE FOR THE TREATMENT OF PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS: THE REMARCA TRIAL
by: D. E. Karateev, et al.
Published: (2016-07-01)

CARDIOVASCULAR RISK ASSESSMENT IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS WITHIN THE REMARCA STUDY: PRELIMINARY DATA
by: D. S. Novikova, et al.
Published: (2015-03-01)

ISSUES OF OPTIMIZATION OF METHOTREXATE THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: G. I. Gridneva, et al.
Published: (2017-03-01)

THE FIRST RUSSIAN STRATEGIC STUDY OF PHARMACOTHERAPY FOR RHEUMATOID ARTHRITIS (REMARCA TRIAL): RESULTS OF 12-MONTH TREATMENT IN 130 PATIENTS
by: D. E. Karateev, et al.
Published: (2015-10-01)

THE FIRST RUSSIAN STRATEGIC STUDY OF PHARMACOTHERAPY FOR RHEUMATOID ARTHRITIS (REMARCA TRIAL): RESULTS OF 12-MONTH TREATMENT IN 130 PATIENTS
by: D. E. Karateev, et al.
Published: (2014-12-01)

THE FIRST RUSSIAN STRATEGIC STUDY OF PHARMACOTHERAPY FOR RHEUMATOID ARTHRITIS (REMARCA TRIAL): RESULTS OF 12-MONTH TREATMENT IN 130 PATIENTS
by: D. E. Karatee, et al.
Published: (2016-12-01)

TIME COURSE OF CHANGES IN BLOOD LIPID PARAMETERS IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS DURING TREAT-TO-TARGET ANTIRHEUMATIC THERAPY: ACCORDING TO 18-MONTH FOLLOW-UP FINDINGS
by: E. V. Udachkina, et al.
Published: (2016-07-01)

IMPACT OF ANTIRHEUMATIC THERAPY ON THE LEVEL OF N-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS
by: I. G. Kirillova, et al.
Published: (2018-07-01)

Left and right ventricular diastolic dysfunction in patients with early rheumatoid arthritis before prescribing disease-modifying antirheumatic therapy
by: I G Kirillova, et al.
Published: (2015-05-01)

ROLE OF MATRIX METALLOPROTEINASE 3 IN PREDICTING THE EFFICIENCY OF THERAPY FOR EARLY RHEUMATOID ARTHRITIS: THE REMARCA TRIAL
by: A. S. Avdeeva, et al.
Published: (2016-03-01)

CHANGES OF CYTOKINE LEVELS DURING THERAPY WITH METHOTREXATE AND ADALIMUMAB IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS (REMARCA STUDY)
by: A. S. Avdeeva, et al.
Published: (2014-06-01)

N-terminal pro-brain natriuretic peptide levels and diastolic dysfunction in patients with early rheumatoid arthritis before the administration of disease-modifying antirheumatic drugs
by: I G Kirillova, et al.
Published: (2016-05-01)

Pharmacotherapy for rheumatoid arthritis in the early 21st century: Russian and international experience
by: E L Nasonov, et al.
Published: (2013-08-01)

Results of one-year treat-to-target strategy in early psoriatic arthritis: data of an open-label REMARCA study
by: T V Korotaeva, et al.
Published: (2018-05-01)

POSSIBILITIES FOR PRESERVING THE RESULTS OF TREATMENT IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS AFTER DOSE REDUCTION AND/OR DISCONTINUATION OF BIOLOGICAL AGENTS: A REMARCA STUDY
by: E. L. Luchikhina, et al.
Published: (2016-12-01)

COMPARATIVE EFFICIENCY AND TOLERABILITY OF CURRENT THERAPIES FOR EARLY RHEUMATOID ARTHRITIS
by: E. V. Fedorenko, et al.
Published: (2015-04-01)

SPECIFIC FEATURES OF AXIAL SKELETON INVOLVEMENT IN EARLY PSORIATIC ARTHRITIS (The REMARCA TRIAL)
by: E. Yu. Loginova, et al.
Published: (2016-09-01)

Cardiovascular diseases in patients with rheumatoid arthritis during long-term methotrexate therapy
by: E V Gerasimova, et al.
Published: (2014-05-01)

PHARMACOTHERAPY FOR RHEUMATOID ARTHRITIS: RUSSIAN AND INTERNATIONAL GUIDELINES
by: E. L. Nasonov
Published: (2016-12-01)

EFFECT OF «TREAT-TO-TARGET» ANTIRHEUMATIC THERAPY ON DIASTOLIC DYSFUNCTION OF THE LEFT AND RIGHT VENTRICLES IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS DURING 18 MONTHS OF OBSERVATION
by: I. G. Kirillova, et al.
Published: (2015-09-01)

MOLECULAR GENETIC TESTING OF ACCP-POSITIVE PATIENTS WITH RHEUMATOID ARTHRITIS AND HIGH INFLAMMATORY DISEASE ACTIVITY (A REMARCA STUDY)
by: I. A. Guseva, et al.
Published: (2018-03-01)

Cardiovascular disease in rheumatic diseases
by: E L Nasonov, et al.
Published: (2016-05-01)

The use of subcutaneous methotrexate from various manufacturers in real clinical practice: a comparative study
by: D. E. Karateev, et al.
Published: (2019-11-01)

WHY ARE THE RECOMMENDED METHOTREXATE DOSES NOT USED FOR THE TREATMENT OF RHEUMATOID ARTHRITIS: WHO IS GUILTY AND WHAT TO DO?
by: Yu. V. Muravyev, et al.
Published: (2017-03-01)

TWELVE-WEEK MULTICENTER OPEN-LABEL RANDOMIZED COMPARATIVE STUDY OF THE EFFICACY AND SAFETY OF METHOTREXATE AS A CONCENTRATED SOLUTION FOR SUBCUTANEOUS ADMINISTRATION AND AS 15-MG TABLETS PER WEEK FOR RHEUMATOID ARTHRITIS
by: Yu. V. Muravyev, et al.
Published: (2016-07-01)

ANTI-INFLAMMATORY THERAPY FOR ATHEROSCLEROSIS: CONTRIBUTION TO AND LESSONS OF RHEUMATOLOGY
by: E. L. Nasonov, et al.
Published: (2017-10-01)

THE TIME COURSE OF CHANGES IN BIOMARKER LEVELS AND THE ULTRASONIC SIGNS OF INFLAMMATION IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: O. G. Alekseeva, et al.
Published: (2015-10-01)

Prospects for rheumatoid arthritis pharmacotherapy: New opportunities and recommendations
by: E L Nasonov
Published: (2016-12-01)

COMPARATIVE EVALUATION OF THE EFFICACY AND SAFETY OF ABATACEPT IN PATIENTS WITH DIFFERENT DURATION OF RHEUMATOID ARTHRITIS
by: M. A. Borisova, et al.
Published: (2017-01-01)

NEW RECOMMENDATIONS FOR THE MANAGEMENT OF RHEUMATOID ARTHRITIS (EULAR, 2013): THE ROLE OF METHOTREXATE
by: Evgeniy L Nasonov, et al.
Published: (2014-03-01)

ANALYSIS OF GENE EXPRESSION IN BLOOD AS AN ADDITIONAL TOOL TO MONITOR METHOTREXATE THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: Elena Vasilyevna Chetina, et al.
Published: (2014-02-01)

Current views on the pharmacotherapy of psoriatic arthritis
by: G. G. Taradin, et al.
Published: (2016-01-01)

CLINICAL AND INSTRUMENTAL CHARACTERISTICS OF AXIAL LESION IN EARLY PERIPHERAL PSORIATIC ARTHRITIS (DATA OF A REMARCA STUDY)
by: E. E. Gubar, et al.
Published: (2018-03-01)

PROJECT: RECOMMENDATIONS ON TREATMENT OF RHEUMATOID ARTHRITIS DEVELOPED BY ALL-RUSSIAN PUBLIC ORGANIZATION «ASSOCIATION OF RHEUMATOLOGISTS OF RUSSIA» – 2014 (PART 1)
by: E. L. Nasonov, et al.
Published: (2015-10-01)

PROJECT: RECOMMENDATIONS ON TREATMENT OF RHEUMATOID ARTHRITIS DEVELOPED BY ALL-RUSSIAN PUBLIC ORGANIZATION «ASSOCIATION OF RHEUMATOLOGISTS OF RUSSIA» – 2014 (PART 1)
by: E. L. Nasonov, et al.
Published: (2014-10-01)

PROJECT: RECOMMENDATIONS ON TREATMENT OF RHEUMATOID ARTHRITIS DEVELOPED BY ALL-RUSSIAN PUBLIC ORGANIZATION «ASSOCIATION OF RHEUMATOLOGISTS OF RUSSIA» – 2014 (PART 1)
by: E. L. Nasonov, et al.
Published: (2016-12-01)

Use of methotrexate in the treatment of psoriasis and psoriatic arthritis
by: Tatiana Viktorovna Korotaeva, et al.
Published: (2013-06-01)

SAFETY OF USING METHOTREXATE SOLUTION FOR SUBCUTANEOUS INJECTIONS IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: Yu. V. Muravyev, et al.
Published: (2015-09-01)

Therapeutic drug monitoring of methotrexate and its metabolites in the red blood cells and mononuclear cells of patients with rheumatoid arthritis
by: G. I. Gridneva, et al.
Published: (2020-11-01)

EARLY RHEUMATOID ARTHRITIS: CURRENT ASPECTS OF ITS DIAGNOSIS AND TREATMENT
by: Yu A Olyunin, et al.
Published: (2010-03-01)